Skip Navigation
Skip Ribbon Commands
Skip to main content
NIAID > Labs & Scientific Resources > Technology Development

Technology Development

Recent Licensing and Collaboration Opportunities

Click the text below to find or hide additional information.

Antimicrobial (Drug) Resistance

PSM Peptides as Vaccine Targets Against Methicillin-Resistant Staphylococcus aureus

 

Biodefense

Protease Deficient Bacillus anthracis With Improved Recombinant Protein Yield Capabilities

Axenically-Produced Coxiella burnetii and Methods for Producing Axenic Coxiella burnetii

 

Cancer

Therapeutic Approach for Autoimmune Diseases, Inflammatory Diseases and Cancers by Blocking CIKS-TRAF6 Interactions

Novel Method of Treating Cancer Using Ixolaris

 

Hepatitis

Infectious Hepatitis E Virus Genotype 3 Recombinants—Prospective Vaccine Candidates and Vector System

A Novel System for Producing Infectious Hepatitis C Virus (HCV) Virions and Development of a Novel Reporter System for Studying HCV Entry

 

Herpes/Herpes Viruses

Prevention and Treatment of Herpes Virus Infection by Inhibition of the JMJD2 Family of Histone Demethylases

Use of Mono-Amine Oxidase Inhibitors To Prevent Herpes Virus Infections and Reactivation From Latency

 

HIV/AIDS

Improved Standard for Immune System Recovery Assay

HIV-1 Neutralization by sCD4-17b a Novel Chimeric Bifunctional Protein for Prevention and Treatment of HIV

Novel System for HIV-1 Vaccine Development 

Mouse Model of Individual Unresponsive to Interferon  

 

Immune and Autoimmune Disorders

Improved Standard for Immune System Recovery Assay 

Mouse Model of Individual Unresponsive to Interferon

Therapeutic Approach for Autoimmune Diseases, Inflammatory Diseases and Cancers by Blocking CIKS-TRAF6 Interactions

 

Neglected Tropical Diseases

see also Parasitic/Vector-Borne Diseases

 

Parasitic/Vector-Borne Diseases

Humanized Monoclonal Antibodies Efficient for Neutralization of Tick-Borne Encephalitis Virus (TBEV)

Rapid Molecular Assays for Specific Detection and Quantitation of Loa loa Microfilaremia

Diagnostic Assays and Methods of Use for Detection of Filarial Infection

Multivalent Vaccines for Rabies Virus and Filoviruses

Method To Create Vaccines for the Prevention of Flavivirus Infections by Targeting Micro-RNA

Compositions and Methods for Controlling Neurotropic Viral Pathogenesis by Micro-RNA Targeting

Compounds That Treat Malaria and Prevent Malaria Transmission  

A Novel Treatment for Malarial Infections

Chondroitin Sulphate A Binding Domains: Potential Vaccine for Malaria

Antigenic Chimeric Tick-Borne Encephalitis Virus/Dengue Virus Type 4 Recombinant Viruses  

Novel Antigen for Use as Vaccine Against Nematode Infection

 

Respiratory Diseases

Treatment of Tuberculosis—Adjuvant Therapies To Increase the Efficiency of Antibiotic Treatments

Poultry Influenza Vaccine

 

Sexually Transmitted Diseases

Use of Mono-Amine Oxidase Inhibitors To Prevent Herpes Virus Infections and Reactivation From Latency

Prevention and Treatment of Herpes Virus Infection by Inhibition of the JMJD2 Family of Histone Demethylases 

 

Research Tools, Animal Models, and Assays

Rapid Molecular Assays for Specific Detection and Quantitation of Loa loa Microfilaremia

Diagnostic Assays and Methods of Use for Detection of Filarial Infection

Improved Standard for Immune System Recovery Assay

Method of Producing Immortalized Primary Human Keratinocytes for HPV Investigation, Testing of Therapeutics, and Skin Graft Generation  

Mouse Model of Individual Unresponsive to Interferon

Mouse IL-12p40 Expressing Cell line  

Microwave-Assisted Freeze Substitution of Biological and Biomedical Samples  

Sound Attenuation Canopy for Reducing Noise Transmitted Through Suspended Ceilings

 

Vaccines

Multivalent Vaccines for Rabies Virus and Filoviruses

Aerosolized Vaccines

Methods To Increase Stability of Recombinant Vaccinia-Vectored Vaccines and Increase Expression of a Foreign Gene Inserted in Such Vaccines

Antigenic Chimeric Tick-Borne Encephalitis Virus/Dengue Virus Type 4 Recombinant Viruses

Novel Antigen for Use as Vaccine Against Nematode Infection

Novel System for HIV-1 Vaccine Development 

Last Updated April 03, 2012

Last Reviewed January 18, 2011